Evaluating Use of Coronary Computed Tomography Angiography in the Emergency Department**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.  by Hlatky, Mark A.
E
o
T
t
M
S
I
i
A
e
c
e
s
c
a
l
E
s
a
d
t
p
s
p
s
(
a
i
l
n
b
u
t
c
C
h
d
a
A
b
p
m
t
t
t
a
i
a
t
W
t
a
a
p
s
T
M
p
o
c
p
u
a
f
R
s
p
c
a
e
c
p
4
c
O
h
d
p
i
f
h
t
a
i
*
v
A
i
B
a
Journal of the American College of Cardiology Vol. 53, No. 18, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2009.02.008EDITORIAL COMMENT
valuating Use
f Coronary Computed
omography Angiography in
he Emergency Department*
ark A. Hlatky, MD
tanford, California
n the U.S. in 2006, a total of 6,392,000 patients were seen
n emergency departments (EDs) with acute chest pain (1).
fter basic evaluation with a clinical history, physical
xamination, electrocardiogram, and initial blood work for
ardiac biomarkers, many such patients have no objective
vidence of active myocardial ischemia. Nevertheless, phy-
icians may be reluctant to send these patients home,
oncerned that they might be among the 2% with a missed
cute myocardial infarction (MI) (2). Consequently, many
ow-risk patients with chest pain are either observed in the
D for extended periods or admitted to the hospital and
ubsequently undergo further cardiac evaluation. A simple,
ccurate, and rapid test that would reliably exclude coronary
isease as the cause of acute chest pain might save a lot of
ime and effort that is currently used to evaluate a low-risk
opulation.
See page 1642
The newest generation of computed tomography (CT)
canners has the temporal and spatial resolution needed to
erform noninvasive coronary angiography. Numerous
tudies of coronary computed tomography angiography
CTA) (3–5) in patients scheduled for an invasive coronary
ngiogram have demonstrated that CTA has high sensitiv-
ty for the detection of obstructive coronary disease but has
ower specificity. Most of these studies have limited perti-
ence to the use of coronary CTA in the ED, however,
ecause patients with acute chest pain differ from those
ndergoing elective coronary angiography. More impor-
antly, prediction of clinical outcomes, not just statistical
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the Stanford University School of Medicine, Stanford, California. Dr. Hlatky
s a member of the Medical Advisory Panel of the Technology Evaluation Center ofa
lue Cross and Blue Shield. He served as a paid consultant to them for preparing an
s yet unpublished analysis for the cost-effectiveness of coronary CTA.orrelation with a gold standard diagnostic test, is a goal of
TA in the ED. There have been relatively few studies that
ave documented clinical outcomes after coronary CTA.
It is a higher standard of evidence to ask whether a
iagnostic test affects clinical outcomes, yet this question is
n essential step in the evaluation of new technology.
lthough there is no doubt that coronary CTA produces
eautiful images, the question is whether taking these
ictures provides any tangible benefit to the patient. Some
ight object that it raises the bar too high to insist that a
est improve clinical outcomes, as most tests in common use
oday have never been held to this standard (6). But
echnologic advances now make it possible to generate
lmost unlimited amounts of detailed data about patients,
ncluding multiple forms of imaging and new biomarkers
nd genetic markers in various combinations and permuta-
ions, all of which have costs and clinical consequences.
ith so many ways to generate data about patients, we need
o ask whether the information will change clinical man-
gement and whether patient outcomes will be improved as
result. The logical conclusion is that we need well-
erformed patient outcome studies, both clinical registry
tudies and randomized clinical trials, to evaluate new tests.
he ROMICAT study. The ROMICAT (Rule Out
yocardial Infarction using Computer Assisted Tomogra-
hy) study (7), a prospective observational study of clinical
utcomes, represents a step forward in the evaluation of
oronary CTA. The design of the ROMICAT study was to
erform coronary CTA in a series of patients after they had
ndergone basic evaluation in the ED and were judged to be
t low clinical risk but were nevertheless deemed to need
urther observation in the hospital. The key feature of the
OMICAT study was that the coronary CTA was done
olely for research purposes, and the results were not
rovided to the clinicians who managed the patients’ clinical
are. Thus, the subsequent clinical outcomes were not
ltered on the basis of CT findings.
A total of 1,869 patients were screened for potential
nrollment in the ROMICAT study. It was found that
oronary CTA was infeasible in 35% of the screened
atients because of a serum creatinine 1.3 mg/dl (n 
54), arrhythmias (n  97), contrast allergy (n  58), or
ontraindications to beta-blocker administration (n  37).
f the 368 patients ultimately enrolled, 8 (2.1%) proved to
ave an acute MI, and a further 23 (6.3%) had a final
iagnosis of acute coronary syndrome. The remaining 337
atients (91.6%) had no evidence of active myocardial
schemia at the time of hospital discharge. Over a mean
ollow-up of 6.2 months, none of these 337 patients died,
ad an MI, or underwent coronary revascularization, with
he caveat that 8% could not be contacted but were
pparently alive (7).
It is reassuring that no adverse events were documented
n the 337 ROMICAT patients without clinical evidence of
cute coronary syndrome. This evidence is fundamentally
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CTA in the ED May 5, 2009:1651–2imited in 2 ways, however. The first limitation is purely
tatistical, in that observing no events in N patients does not
stablish the event rate is 0%. The “rule of three” says an
bservation of 0 events has a rough 95% upper confidence
imit of 3/N, so in the ROMICAT study the statistical
pper confidence limit for the adverse cardiac event rate is
pproximately 0.9% (3 of 337). The second fundamental
imitation in any study of prognosis is the rate of loss to
ollow-up. Complete follow-up of patients from the ED is
articularly difficult, and although 92% of patients in the
OMICAT study were contacted successfully, 8% were
ot, and arguably anyone who had a poor clinical outcome
ight be more difficult to contact. So, although the low rate
f adverse cardiac events in the ROMICAT study is
eassuring, larger studies with more complete follow-up will
e needed to assess more fully the prognostic implications of
coronary CTA in the ED.
The 337 patients without acute coronary syndrome in the
OMICAT study had a variety of findings in their coronary
TA: 183 (54%) had normal coronaries, 110 (33%) had
onobstructive coronary atherosclerosis, and 44 (13%) had
ndeterminate studies or a lumenal diameter narrowing of
0% or more. By design, none of these findings were
rovided to the clinicians managing the patients’ care, so it
s uncertain what the clinicians would have done differently
ased on the CTA results. It is quite likely that most of the
54 stress tests would not have been performed in this
opulation, at least among the 183 subjects with normal
oronary arteries. But it is also likely that more than 13
atients would have undergone an invasive coronary angio-
ram, and some would surely have had coronary revascular-
zation, as 154 patients in the ROMICAT study had CT
vidence of coronary atherosclerosis. The ultimate effect of
ore aggressive treatment is uncertain, but it is interesting
hat no adverse cardiac events were seen in follow-up among
hese 154 patients with a CT finding of coronary athero-
clerosis but no evidence of ischemia.
Use of coronary CTA has the potential to shorten the
ime of evaluation for low-risk patients with chest pain in
he ED. The CT exam in the ROMICAT study took only
6 min to perform “door to door,” which is much less than
he average hospital stay of 40.5 h. A previously published
andomized trial of coronary CTA in patients with acute
hest pain (8) showed that the time spent in the ED was
ignificantly reduced by use of CTA compared with stan-
ard observation and stress testing. But the overall effects of
T angiography on costs of care and clinical outcomes are Kore difficult to project, as 6 patients underwent coronary
evascularization after evaluation with CTA compared with
nly 1 patient randomized to standard care (8).
onclusions. This study shows that use of coronary CTA
n low-risk patients with chest pain in the ED is a promising
evelopment. A finding of normal coronary arteries will
ikely obviate additional tests and speed patient discharge to
ome and appears to be associated with a good short-term
rognosis. A finding of some degree of coronary atheroscle-
osis might not, however, “clear the air,” as further investi-
ations are likely with either stress testing or invasive
oronary angiography (or both). Whether patient outcomes
re ultimately improved by adopting a strategy of coronary
TA in the ED will require further investigation, optimally
y randomized trials with adequate sample size to detect
mportant differences in hard cardiac outcomes.
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